News

(the "Company" or "Lahontan") is pleased to announce a non-brokered private placement financing for gross proceeds of up to $2,000,000 through the issuance of up to 40,000,000 units (the "Units ...
In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management.
Not all foot pain is created equal, and we sat down with Sports Medicine Physician Dr. Kelly Krei to talk about foot pain, what causes pain on the top of the foot, and treatment options that are ...
"LPT-CBD demonstrates sustained pharmacokinetics and has shown efficacy across multiple animal models of chronic pain. We are extremely proud of our team's efforts in advancing the innovation ...
which fees aggregated $1,000 and were paid by issuing 806 Units at deemed price of $1.24 per Unit. The proceeds from the Private Placement will be used to fund the Company’s business focused on the ...
Bulls guard Tre Jones was still in his two-week window to have his left foot sprain re-evaluated, but was also still in a walking boot and experiencing pain. Rob Gray/AP Share Guard Tre Jones ...
A must-have in the later stages of any pregnancy, this Maternity TENS Unit from Boots is incredibly easy to use and designed to help relieve pain at the onset of labour. Simply apply the four pads ...
In some people there is very little or no numbness. In these people pain can often be triggered by gentle touch and movement across the skin (for example, bed sheets brushing across a foot, putting on ...
The net proceeds from the sale of the Hard Dollar Units are expected to be used by the Company for working capital and general corporate purposes. All securities issued under the Private Placement are ...
the Company has closed a non-brokered private placement through the issuance of 6,082,000 units (each, a "Unit") at a price of $0.25 per Unit for aggregate gross proceeds of $1,520,500 (the ...
(“Opus One” or the “Company”), is pleased to announce a non-brokered private placement for gross proceeds of up to $2,000,000 (the “Offering”) from the sale of (i) units of the Company at a price of ...